In conclusion, decreasing mitochondrial ROS levels via muscle-specific expression of a mitochondrial-targeted catalase significantly improved muscle strength and the neuromuscular junction morphology following AVF surgery in mice with CKD. Here, CAT is linked to chronic kidney disease.